NCT01399255View on ClinicalTrials.gov

Comparative Bioequivalence Study of Wockhardt's Insulin Analogue Lispro (Listro™) With Humalog® in Healthy Subjects

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 30, 2011

Primary Completion Date

May 31, 2012

Study Completion Date

June 30, 2012

Conditions
Bioequivalence in Healthy Subjects
Interventions
BIOLOGICAL

Insulin lispro

Dosage form- Subcutaneous Injection

Trial Locations (1)

91911

Profil Institute for Clinical Research, Inc., Chula Vista

Sponsors

Lead Sponsor

Wockhardt
All Listed Sponsors
lead

Wockhardt

INDUSTRY

NCT01399255 - Comparative Bioequivalence Study of Wockhardt's Insulin Analogue Lispro (Listro™) With Humalog® in Healthy Subjects | Biotech Hunter | Biotech Hunter